methylprednisolone acetate has been researched along with Carpal Tunnel Syndrome in 12 studies
Methylprednisolone Acetate: Methylprednisolone derivative that is used as an anti-inflammatory agent for the treatment of ALLERGY and ALLERGIC RHINITIS; ASTHMA; and BURSITIS; and for the treatment of ADRENAL INSUFFICIENCY.
methylprednisolone acetate : An acetate ester resulting from the formal condensation of the 21-hydroxy function of 6alpha-methylprednisolone compound with acetic acid.
Carpal Tunnel Syndrome: Entrapment of the MEDIAN NERVE in the carpal tunnel, which is formed by the flexor retinaculum and the CARPAL BONES. This syndrome may be associated with repetitive occupational trauma (CUMULATIVE TRAUMA DISORDERS); wrist injuries; AMYLOID NEUROPATHIES; rheumatoid arthritis (see ARTHRITIS, RHEUMATOID); ACROMEGALY; PREGNANCY; and other conditions. Symptoms include burning pain and paresthesias involving the ventral surface of the hand and fingers which may radiate proximally. Impairment of sensation in the distribution of the median nerve and thenar muscle atrophy may occur. (Joynt, Clinical Neurology, 1995, Ch51, p45)
Excerpt | Relevance | Reference |
---|---|---|
"double steroid injections in the treatment of carpal tunnel syndrome (CTS) in a randomised double-blind controlled trial." | 2.71 | Single vs. two steroid injections for carpal tunnel syndrome: a randomised clinical trial. ( Chiu, JH; Hui, AC; Lo, SK; Poon, WF; Wong, L; Wong, SM, 2005) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (16.67) | 18.2507 |
2000's | 5 (41.67) | 29.6817 |
2010's | 5 (41.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chesterton, LS | 2 |
Blagojevic-Bucknall, M | 2 |
Burton, C | 2 |
Dziedzic, KS | 2 |
Davenport, G | 2 |
Jowett, SM | 1 |
Myers, HL | 2 |
Oppong, R | 1 |
Rathod-Mistry, T | 1 |
van der Windt, DA | 2 |
Hay, EM | 2 |
Roddy, E | 2 |
Kamel, SR | 1 |
Sadek, HA | 1 |
Hamed, A | 1 |
Sayed, OA | 1 |
Mahmud, MH | 1 |
Mohamed, FA | 1 |
El Sagher, GM | 1 |
Aly, LH | 1 |
Rathod, T | 1 |
Jowet, SM | 1 |
Badarny, S | 1 |
Rawashdeh, H | 1 |
Meer, J | 1 |
Abed, S | 1 |
Habib, G | 1 |
Park, GY | 1 |
Kim, SK | 1 |
Park, JH | 1 |
Hui, AC | 2 |
Wong, SM | 2 |
Tang, A | 1 |
Mok, V | 1 |
Hung, LK | 1 |
Wong, KS | 1 |
Agarwal, V | 1 |
Singh, R | 1 |
Sachdev, A | 1 |
Shekhar, S | 1 |
Goel, D | 1 |
Lo, SK | 1 |
Chiu, JH | 1 |
Poon, WF | 1 |
Wong, L | 1 |
Nalamachu, S | 1 |
Crockett, RS | 1 |
Mathur, D | 1 |
Tavares, SP | 1 |
Giddins, GE | 1 |
Mondelli, M | 1 |
Porta, PD | 1 |
Zalaffi, A | 1 |
Rossi, A | 1 |
Celiker, R | 1 |
Arslan, S | 1 |
Inanici, F | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Randomised, Multicentre, Open Label, Parallel Group Pragmatic Clinical Trial of Local Steroid Injection Versus Night Splinting in Mild to Moderate Carpal Tunnel Syndrome (CTS)[NCT02038452] | Phase 4 | 234 participants (Actual) | Interventional | 2014-04-30 | Completed | ||
The Use of N-acetylcysteine Supplementation in Addition to Night Splinting for Treatment of Mild to Moderate Carpal Tunnel Syndrome: A Randomized, Double-blind, Placebo-controlled Trial[NCT04460521] | Phase 4 | 240 participants (Anticipated) | Interventional | 2021-08-01 | Recruiting | ||
A Prospective, Randomized, Double-Blind, Cross-over Study of Lidocaine Patch 1.8% in Patients With Moderate to Severe Pain From Carpal Tunnel Syndrome[NCT04245371] | Phase 4 | 45 participants (Actual) | Interventional | 2020-02-24 | Completed | ||
Randomized Controlled Trial of Ultrasound-guided Steroid Injection Versus Wrist Splint in Patients With Carpal Tunnel Syndrome[NCT04515966] | Phase 4 | 70 participants (Anticipated) | Interventional | 2020-12-01 | Recruiting | ||
The Therapeutic Effect and Quality of Life After Local Injection of Steroid VS. Glucose 5% for Carpal Tunnel Syndrome : Double-blinded Clinical Trial[NCT05496764] | Phase 4 | 52 participants (Anticipated) | Interventional | 2021-12-01 | Recruiting | ||
Combined Effect of Insulin and Sodium Hyaluronate Injection Guided by Ultrasound in Carpal Tunnel Syndrome[NCT04142411] | Early Phase 1 | 90 participants (Anticipated) | Interventional | 2019-11-30 | Not yet recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Comparison of BCTQ functional limitations between treatment groups at 6 months follow-up (1-5 scale, higher score indicates more functional impairment). BCTQ: Boston Carpal Tunnel Questionnaire (NCT02038452)
Timeframe: 6 months
Intervention | score on a scale (Mean) |
---|---|
Steroid Injection | 1.91 |
Wrist Splint | 1.89 |
Sensitivity analysis for comparison of BCTQ function limitations between treatment groups at 6 months follow-up (scale 1-5, higher score indicates more functional impairment) on participants with complete data. BCTQ: Boston Carpal Tunnel Questionnaire (NCT02038452)
Timeframe: 6 months
Intervention | score on a scale (Mean) |
---|---|
Steroid Injection | 1.85 |
Wrist Splint | 1.88 |
Per protocol analysis for comparison of BCTQ functional limitations between treatment groups at 6 months follow-up (scale 1-5, higher score indicates more functional impairment) on participants with complete data. BCTQ: Boston Carpal Tunnel Questionnaire (NCT02038452)
Timeframe: 6 months
Intervention | score on a scale (Mean) |
---|---|
Steroid Injection | 1.89 |
Wrist Splint | 1.84 |
Comparison of BCTQ functional limitations between treatment groups at 6 weeks follow-up (1-5 scale, higher score indicates more severe functional impairment). BCTQ: Boston Carpal Tunnel Questionnaire (NCT02038452)
Timeframe: 6 weeks
Intervention | score on a scale (Mean) |
---|---|
Steroid Injection | 1.88 |
Wrist Splint | 2.09 |
Sensitivity analysis for comparison of overall BCTQ between treatment groups at 6 weeks follow-up (scale 1-5, higher score indicates more functional impairment) on participants with complete data. BCTQ: Boston Carpal Tunnel Questionnaire (NCT02038452)
Timeframe: 6 weeks
Intervention | score on a scale (Mean) |
---|---|
Steroid Injection | 1.86 |
Wrist Splint | 2.10 |
"Per protocol analysis for comparison of BCTQ functional limitations between treatment groups at 6 weeks follow-up (scale 1-5, higher score indicates more functional impairment) on participants with complete data.~BCTQ: Boston Carpal Tunnel Questionnaire" (NCT02038452)
Timeframe: 6 weeks
Intervention | score on a scale (Mean) |
---|---|
Steroid Injection | 1.88 |
Wrist Splint | 2.06 |
Comparison of overall BCTQ between treatment groups at 6 months follow-up (1-5 scale, higher score indicates more severe symptoms and functional impairment). BCTQ: Boston Carpal Tunnel Questionnaire (NCT02038452)
Timeframe: 6 months
Intervention | score on a scale (Mean) |
---|---|
Steroid Injection | 2.15 |
Wrist Splint | 2.06 |
Sensitivity analysis for comparison of overall BCTQ between treatment groups at 6 months follow-up (scale 1-5, higher score indicates more severe symptoms and functional impairment) on participants with complete data. BCTQ: Boston Carpal Tunnel Questionnaire (NCT02038452)
Timeframe: 6 months
Intervention | score on a scale (Mean) |
---|---|
Steroid Injection | 2.08 |
Wrist Splint | 2.04 |
Per protocol analysis for comparison of overall BCTQ between treatment groups at 6 months follow-up (scale 1-5, higher score indicates more severe symptoms and functional impairment) on participants with complete data. BCTQ: Boston Carpal Tunnel Questionnaire (NCT02038452)
Timeframe: 6 months
Intervention | score on a scale (Mean) |
---|---|
Steroid Injection | 2.09 |
Wrist Splint | 2.02 |
Sensitivity analysis for comparison of overall BCTQ between treatment groups at 6 weeks follow-up (scale 1-5, higher score indicates more severe symptoms and functional impairment) on participants with complete data. BCTQ: Boston Carpal Tunnel Questionnaire (NCT02038452)
Timeframe: 6 weeks
Intervention | score on a scale (Mean) |
---|---|
Steroid Injection | 1.95 |
Wrist Splint | 2.29 |
Per protocol analysis for comparison of overall BCTQ between treatment groups at 6 weeks follow-up (scale 1-5, higher score indicates more severe symptoms and functional impairment) on participants with complete data. BCTQ: Boston Carpal Tunnel Questionnaire (NCT02038452)
Timeframe: 6 weeks
Intervention | score on a scale (Mean) |
---|---|
Steroid Injection | 1.96 |
Wrist Splint | 2.28 |
Subgroup analysis was performed in patients who did not receive the intervention of their preference. Comparison of overall BCTQ between treatment groups at 6 weeks follow-up (scale 1-5, higher score indicates more severe symptoms and functional impairment) on participants with complete data. BCTQ: Boston Carpal Tunnel Questionnaire (NCT02038452)
Timeframe: 6 weeks
Intervention | score on a scale (Mean) |
---|---|
Steroid Injection | 2.15 |
Wrist Splint | 2.40 |
Subgroup analysis was performed in patients who did not state a preference of intervention. Comparison of overall BCTQ between treatment groups at 6 weeks follow-up (scale 1-5, higher score indicates more severe symptoms and functional impairment) on participants with complete data. BCTQ: Boston Carpal Tunnel Questionnaire (NCT02038452)
Timeframe: 6 weeks
Intervention | score on a scale (Mean) |
---|---|
Steroid Injection | 2.03 |
Wrist Splint | 2.26 |
Subgroup analysis was performed in patients who preferred injection. Comparison of overall BCTQ between treatment groups at 6 weeks follow-up (scale 1-5, higher score indicates more severe symptoms and functional impairment) on participants with complete data. BCTQ: Boston Carpal Tunnel Questionnaire (NCT02038452)
Timeframe: 6 weeks
Intervention | score on a scale (Mean) |
---|---|
Steroid Injection | 1.88 |
Wrist Splint | 2.40 |
Subgroup analysis was performed in patients who preferred splint. Comparison of overall BCTQ between treatment groups at 6 weeks follow-up (higher score indicates more severe symptoms and functional impairment) on participants with complete data. BCTQ: Boston Carpal Tunnel Questionnaire (NCT02038452)
Timeframe: 6 weeks
Intervention | score on a scale (Mean) |
---|---|
Steroid Injection | 2.15 |
Wrist Splint | 2.40 |
Subgroup analysis was performed in patients who were allocated the intervention of their preference. Comparison of overall BCTQ between treatment groups at 6 weeks follow-up (scale 1-5, higher score indicates more severe symptoms and functional impairment) on participants with complete data. BCTQ: Boston Carpal Tunnel Questionnaire (NCT02038452)
Timeframe: 6 weeks
Intervention | score on a scale (Mean) |
---|---|
Steroid Injection | 1.88 |
Wrist Splint | 2.19 |
Comparison of overall BCTQ between treatment groups across all time points (6 weeks, 6-, 12-, and 24 month follow-up). Scale 1-5, higher score indicates more severe symptoms and functional impairment). Results are presented at 12 months. BCTQ: Boston Carpal Tunnel Questionnaire. (NCT02038452)
Timeframe: 12 months
Intervention | score on a scale (Mean) |
---|---|
Steroid Injection | 1.98 |
Wrist Splint | 2.05 |
Comparison of overall BCTQ between treatment groups across all time points (6 weeks, 6-, 12-, and 24 month follow-up. Scale 1-5, higher score indicates more severe symptoms and functional impairment. Results are presented at 6 months. BCTQ: Boston Carpal Tunnel Questionnaire. (NCT02038452)
Timeframe: 6 months
Intervention | score on a scale (Mean) |
---|---|
Steroid Injection | 2.08 |
Wrist Splint | 2.04 |
Comparison of overall BCTQ between treatment groups across all time points (6 weeks, 6-, 12-, and 24 month follow-up). Scale 1-5, higher score indicates more severe symptoms and functional impairment. Results are presented at 6 weeks. BCTQ: Boston Carpal Tunnel Questionnaire (NCT02038452)
Timeframe: 6 weeks
Intervention | score on a scale (Mean) |
---|---|
Steroid Injection | 1.95 |
Wrist Splint | 2.30 |
Comparison of BCTQ symptom severity between treatment groups at 6 months follow-up (1-5 scale, higher score indicates more severe symptoms). BCTQ: Boston Carpal Tunnel Questionnaire (NCT02038452)
Timeframe: 6 months
Intervention | score on a scale (Mean) |
---|---|
Steroid Injection | 2.33 |
Wrist Splint | 2.18 |
"Sensitivity analysis for comparison of BCTQ symptom severity between treatment groups at 6 months follow-up (scale 1-5, higher score indicates more severe symptoms) on participants with complete data. BCTQ:~Boston Carpal Tunnel Questionnaire" (NCT02038452)
Timeframe: 6 months
Intervention | score on a scale (Mean) |
---|---|
Steroid Injection | 2.29 |
Wrist Splint | 2.16 |
"Per protocol analysis for comparison of BCTQ symptom severity between treatment groups at 6 months follow-up (scale 1-5, higher score indicates more severe symptoms) on participants with complete data. BCTQ:~Boston Carpal Tunnel Questionnaire" (NCT02038452)
Timeframe: 6 months
Intervention | score on a scale (Mean) |
---|---|
Steroid Injection | 2.28 |
Wrist Splint | 2.15 |
Comparison of BCTQ symptom severity between treatment groups at 6 weeks follow-up (scale 1-5, higher score indicates more severe symptoms). BCTQ: Boston Carpal Tunnel Questionnaire (NCT02038452)
Timeframe: 6 weeks
Intervention | score on a scale (Mean) |
---|---|
Steroid Injection | 2.12 |
Wrist Splint | 2.43 |
"Sensitivity analysis for comparison of BCTQ symptom severity between treatment groups at 6 weeks follow-up (scale 1-5, higher score indicates more severe symptoms) on participants with complete data. BCTQ:~Boston Carpal Tunnel Questionnaire" (NCT02038452)
Timeframe: 6 weeks
Intervention | score on a scale (Mean) |
---|---|
Steroid Injection | 2.07 |
Wrist Splint | 2.44 |
"Per protocol analysis for comparison of BCTQ symptom severity between treatment groups at 6 weeks follow-up (scale 1-5, higher score indicates more severe symptoms) on participants with complete data. BCTQ:~Boston Carpal Tunnel Questionnaire" (NCT02038452)
Timeframe: 6 weeks
Intervention | score on a scale (Mean) |
---|---|
Steroid Injection | 2.07 |
Wrist Splint | 2.44 |
Comparison of pain scores between treatment groups at 6 months follow-up. 0-10 scale, higher score indicates more pain. (NCT02038452)
Timeframe: 6 months
Intervention | units on a scale (Mean) |
---|---|
Steroid Injection | 4.32 |
Wrist Splint | 3.46 |
Sensitivity analysis for comparison of pain scores between treatment groups at 6 months follow-up (scale 0-10, higher score indicates more pain) on participants with complete data. (NCT02038452)
Timeframe: 6 months
Intervention | score on a scale (Mean) |
---|---|
Steroid Injection | 4.11 |
Wrist Splint | 3.29 |
Per protocol analysis for comparison of pain scores between treatment groups at 6 months follow-up (scale 0-10, higher score indicates more pain) on participants with complete data. (NCT02038452)
Timeframe: 6 months
Intervention | score on a scale (Mean) |
---|---|
Steroid Injection | 4.11 |
Wrist Splint | 3.38 |
Comparison of pain scores between treatment groups at 6 weeks follow-up (0-10 scale, higher score indicates more pain). (NCT02038452)
Timeframe: 6 weeks
Intervention | units on a scale (Mean) |
---|---|
Steroid Injection | 3.42 |
Wrist Splint | 4.28 |
Sensitivity analysis for comparison of pain scores between treatment groups at 6 weeks follow-up (scale 0-10, higher score indicates more pain) on participants with complete data. (NCT02038452)
Timeframe: 6 weeks
Intervention | score on a scale (Mean) |
---|---|
Steroid Injection | 3.33 |
Wrist Splint | 4.28 |
Per protocol analysis for comparison of pain scores between treatment groups at 6 weeks follow-up (higher score indicates more pain) on participants with complete data. (NCT02038452)
Timeframe: 6 weeks
Intervention | score on a scale (Mean) |
---|---|
Steroid Injection | 3.33 |
Wrist Splint | 4.44 |
Comparison of pain scores between treatment groups across all time points (6 weeks, 6-, 12-, and 24 month follow-up). Scale 0-10, higher score indicates more pain. Results are presented at 12 months. (NCT02038452)
Timeframe: 12 months
Intervention | score on a scale (Mean) |
---|---|
Steroid Injection | 3.17 |
Wrist Splint | 3.14 |
Comparison of pain scores between treatment groups across all time points (6 weeks, 6-, 12-, and 24 month follow-up). Scale 0-10, higher score indicates more pain. Results are presented at 24 months. (NCT02038452)
Timeframe: 24 months
Intervention | score on a scale (Mean) |
---|---|
Steroid Injection | 2.81 |
Wrist Splint | 2.40 |
Comparison of pain scores between treatment groups across all time points (6 weeks, 6-, 12-, and 24 month follow-up). Scale 0-10, higher score indicates more pain. Results are presented at 6 months. (NCT02038452)
Timeframe: 6 months
Intervention | score on a scale (Mean) |
---|---|
Steroid Injection | 4.11 |
Wrist Splint | 3.29 |
Comparison of pain scores between treatment groups across all time points (6 weeks, 6-, 12-, and 24 month follow-up). Scale 0-10, higher score indicates more pain. Results are presented at 6 weeks. (NCT02038452)
Timeframe: 6 weeks
Intervention | score on a scale (Mean) |
---|---|
Steroid Injection | 3.33 |
Wrist Splint | 4.28 |
Cost of interventions at 12 months (NCT02038452)
Timeframe: 12 months
Intervention | UK Pounds (Mean) |
---|---|
Steroid Injection | 508.69 |
Wrist Splint | 395.54 |
Cost of interventions at 24 months (NCT02038452)
Timeframe: 24 months
Intervention | UK Pounds (Mean) |
---|---|
Steroid Injection | 657.87 |
Wrist Splint | 586.77 |
Cost of interventions at 6 months (NCT02038452)
Timeframe: 6 months
Intervention | UK Pounds (Mean) |
---|---|
Steroid Injection | 346.78 |
Wrist Splint | 313.24 |
Complete case analysis on the cost of interventions at 6 months (NCT02038452)
Timeframe: 6 months
Intervention | UK Pounds (Mean) |
---|---|
Steroid Injection | 353.48 |
Wrist Splint | 306.42 |
"The Quality Adjusted Life Years (QALYs) is a measure of the state of health of a person/group in which the benefits, in terms of length of life, are adjusted to reflect the quality of life. One QALY is equal to 1 year of life in perfect health. QALYs are calculated by estimating the years of life remaining for a patient following a particular treatment/intervention and weighting each year with a quality-of-life score (on a 0 to 1 scale). It is often measured in terms of the person's ability to carry out the activities of daily life and freedom from pain and mental disturbance. The QALY does not have a maximum score.~Cross-walk tariff: Crosswalk value sets were developed from a study of respondents who completed both the EQ-5D-3L and EQ-5D-5L. The crosswalk used a non-parametric response mapping method to predict values that are linked to the EQ-5D-3L value set. In short, the cross-walk tariff maps EQ-5D-5L values." (NCT02038452)
Timeframe: 12 months
Intervention | score on a scale (Mean) |
---|---|
Steroid Injection | 0.723 |
Wrist Splint | 0.736 |
"The Quality Adjusted Life Years (QALYs) is a measure of the state of health of a person/group in which the benefits, in terms of length of life, are adjusted to reflect the quality of life. One QALY is equal to 1 year of life in perfect health. QALYs are calculated by estimating the years of life remaining for a patient following a particular treatment/intervention and weighting each year with a quality-of-life score (on a 0 to 1 scale). It is often measured in terms of the person's ability to carry out the activities of daily life and freedom from pain and mental disturbance. The QALY does not have a maximum score.~Cross-walk tariff: Crosswalk value sets were developed from a study of respondents who completed both the EQ-5D-3L and EQ-5D-5L. The crosswalk used a non-parametric response mapping method to predict values that are linked to the EQ-5D-3L value set. In short, the cross-walk tariff maps EQ-5D-5L values." (NCT02038452)
Timeframe: 24 months
Intervention | score on a scale (Mean) |
---|---|
Steroid Injection | 1.461 |
Wrist Splint | 1.497 |
"The Quality Adjusted Life Years (QALYs) is a measure of the state of health of a person/group in which the benefits, in terms of length of life, are adjusted to reflect the quality of life. One QALY is equal to 1 year of life in perfect health. QALYs are calculated by estimating the years of life remaining for a patient following a particular treatment/intervention and weighting each year with a quality-of-life score (on a 0 to 1 scale). It is often measured in terms of the person's ability to carry out the activities of daily life and freedom from pain and mental disturbance. The QALY does not have a maximum score.~Cross-walk tariff: Crosswalk value sets were developed from a study of respondents who completed both the EQ-5D-3L and EQ-5D-5L. The crosswalk used a non-parametric response mapping method to predict values that are linked to the EQ-5D-3L value set. In short, the cross-walk tariff maps EQ-5D-5L values." (NCT02038452)
Timeframe: 6 months
Intervention | score on a scale (Mean) |
---|---|
Steroid Injection | 0.354 |
Wrist Splint | 0.356 |
Comparison of overall BCTQ between treatment groups across all time points (6 weeks, 6-, 12-, and 24 month follow-up). Scale 1-5, higher score indicates more severe symptoms and functional impairment. Results are presented at 24 months. BCTQ: Boston Carpal Tunnel Questionnaire (NCT02038452)
Timeframe: 24 months
Intervention | score on a scale (Mean) |
---|---|
Steroid Injection | 1.79 |
Wrist Splint | 1.73 |
Comparison of overall BCTQ between treatment groups at 6 weeks follow-up (scale 1-5, higher score indicates more severe symptoms and functional impairment). BCTQ: Boston Carpal Tunnel Questionnaire (NCT02038452)
Timeframe: 6 weeks
Intervention | score on a scale (Mean) |
---|---|
Steroid Injection | 2.02 |
Wrist Splint | 2.29 |
9 trials available for methylprednisolone acetate and Carpal Tunnel Syndrome
Article | Year |
---|---|
The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, randomised controlled trial.
Topics: Adult; Aged; Anti-Inflammatory Agents; Carpal Tunnel Syndrome; Cost-Benefit Analysis; Female; Humans | 2018 |
The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, randomised controlled trial.
Topics: Adult; Aged; Anti-Inflammatory Agents; Carpal Tunnel Syndrome; Cost-Benefit Analysis; Female; Humans | 2018 |
The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, randomised controlled trial.
Topics: Adult; Aged; Anti-Inflammatory Agents; Carpal Tunnel Syndrome; Cost-Benefit Analysis; Female; Humans | 2018 |
The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, randomised controlled trial.
Topics: Adult; Aged; Anti-Inflammatory Agents; Carpal Tunnel Syndrome; Cost-Benefit Analysis; Female; Humans | 2018 |
The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, randomised controlled trial.
Topics: Adult; Aged; Anti-Inflammatory Agents; Carpal Tunnel Syndrome; Cost-Benefit Analysis; Female; Humans | 2018 |
The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, randomised controlled trial.
Topics: Adult; Aged; Anti-Inflammatory Agents; Carpal Tunnel Syndrome; Cost-Benefit Analysis; Female; Humans | 2018 |
The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, randomised controlled trial.
Topics: Adult; Aged; Anti-Inflammatory Agents; Carpal Tunnel Syndrome; Cost-Benefit Analysis; Female; Humans | 2018 |
The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, randomised controlled trial.
Topics: Adult; Aged; Anti-Inflammatory Agents; Carpal Tunnel Syndrome; Cost-Benefit Analysis; Female; Humans | 2018 |
The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, randomised controlled trial.
Topics: Adult; Aged; Anti-Inflammatory Agents; Carpal Tunnel Syndrome; Cost-Benefit Analysis; Female; Humans | 2018 |
The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, randomised controlled trial.
Topics: Adult; Aged; Anti-Inflammatory Agents; Carpal Tunnel Syndrome; Cost-Benefit Analysis; Female; Humans | 2018 |
The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, randomised controlled trial.
Topics: Adult; Aged; Anti-Inflammatory Agents; Carpal Tunnel Syndrome; Cost-Benefit Analysis; Female; Humans | 2018 |
The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, randomised controlled trial.
Topics: Adult; Aged; Anti-Inflammatory Agents; Carpal Tunnel Syndrome; Cost-Benefit Analysis; Female; Humans | 2018 |
The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, randomised controlled trial.
Topics: Adult; Aged; Anti-Inflammatory Agents; Carpal Tunnel Syndrome; Cost-Benefit Analysis; Female; Humans | 2018 |
The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, randomised controlled trial.
Topics: Adult; Aged; Anti-Inflammatory Agents; Carpal Tunnel Syndrome; Cost-Benefit Analysis; Female; Humans | 2018 |
The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, randomised controlled trial.
Topics: Adult; Aged; Anti-Inflammatory Agents; Carpal Tunnel Syndrome; Cost-Benefit Analysis; Female; Humans | 2018 |
The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, randomised controlled trial.
Topics: Adult; Aged; Anti-Inflammatory Agents; Carpal Tunnel Syndrome; Cost-Benefit Analysis; Female; Humans | 2018 |
Ultrasound-guided insulin injection for carpal tunnel syndrome in type 2 diabetes mellitus patients.
Topics: Adolescent; Adult; Aged; Carpal Tunnel Syndrome; Diabetes Mellitus, Type 2; Electrophysiology; Femal | 2019 |
Ultrasound-guided insulin injection for carpal tunnel syndrome in type 2 diabetes mellitus patients.
Topics: Adolescent; Adult; Aged; Carpal Tunnel Syndrome; Diabetes Mellitus, Type 2; Electrophysiology; Femal | 2019 |
Ultrasound-guided insulin injection for carpal tunnel syndrome in type 2 diabetes mellitus patients.
Topics: Adolescent; Adult; Aged; Carpal Tunnel Syndrome; Diabetes Mellitus, Type 2; Electrophysiology; Femal | 2019 |
Ultrasound-guided insulin injection for carpal tunnel syndrome in type 2 diabetes mellitus patients.
Topics: Adolescent; Adult; Aged; Carpal Tunnel Syndrome; Diabetes Mellitus, Type 2; Electrophysiology; Femal | 2019 |
The clinical and cost effectiveness of steroid injection compared with night splints for carpal tunnel syndrome: the INSTINCTS randomised clinical trial study protocol.
Topics: Adult; Carpal Tunnel Syndrome; Cost-Benefit Analysis; Glucocorticoids; Hand; Humans; Injections; Met | 2016 |
Repeated electrophysiologic studies in patients with carpal tunnel syndrome following local corticosteroid injection using a novel approach.
Topics: Adult; Aged; Anti-Inflammatory Agents; Carpal Tunnel Syndrome; Electromyography; Female; Follow-Up S | 2011 |
Long-term outcome of carpal tunnel syndrome after conservative treatment.
Topics: Administration, Oral; Anti-Inflammatory Agents; Carpal Tunnel Syndrome; Humans; Injections; Methylpr | 2004 |
A prospective study of the long-term efficacy of local methyl prednisolone acetate injection in the management of mild carpal tunnel syndrome.
Topics: Adult; Aged; Anti-Inflammatory Agents; Carpal Tunnel Syndrome; Electromyography; Female; Follow-Up S | 2005 |
Single vs. two steroid injections for carpal tunnel syndrome: a randomised clinical trial.
Topics: Analgesia; Anti-Inflammatory Agents; Carpal Tunnel Syndrome; Double-Blind Method; Female; Humans; In | 2005 |
Lidocaine patch 5 for carpal tunnel syndrome: how it compares with injections: a pilot study.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Analysis of Variance; Anesthetics, Local; Anti-I | 2006 |
Corticosteroid injection vs. nonsteroidal antiinflammatory drug and splinting in carpal tunnel syndrome.
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Carpal Tunnel Syndrome; El | 2002 |
3 other studies available for methylprednisolone acetate and Carpal Tunnel Syndrome
Article | Year |
---|---|
Median nerve injury after carpal tunnel injection serially followed by ultrasonographic, sonoelastographic, and electrodiagnostic studies.
Topics: Anti-Inflammatory Agents; Carpal Tunnel Syndrome; Female; Humans; Injections, Intra-Articular; Media | 2011 |
Nerve injury following steroid injection for carpal tunnel syndrome. A report of two cases.
Topics: Anti-Inflammatory Agents; Carpal Tunnel Syndrome; Female; Humans; Male; Median Nerve; Methylpredniso | 1996 |
Carpal tunnel syndrome in amyotrophic lateral sclerosis and late onset cerebellar ataxia.
Topics: Aged; Amyotrophic Lateral Sclerosis; Anti-Inflammatory Agents; Carpal Tunnel Syndrome; Cerebellar At | 1996 |